Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database

Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database

Takeo Hata,1 Atsushi Hirata,2 Ryosuke Ota,2 Keiko Hosohata,3 Masami Nishihara,1 Masashi Neo,1 Takahiro Katsumata1 1Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan; 2Department of Pharmacy, Kindai University Nara Hospital, Ikoma, Nara, Japan; 3Edu...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, Katsumata T
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Dove Medical Press 2022-08-01
Seri Bilgileri:Therapeutics and Clinical Risk Management
Konular:
“arthritis
juvenile”
“antirheumatic agents”
“biological products”
“database”
Online Erişim:https://www.dovepress.com/biologic-disease-modifying-and-other-anti-rheumatic-drugs-use-in-patie-peer-reviewed-fulltext-article-TCRM

Internet

https://www.dovepress.com/biologic-disease-modifying-and-other-anti-rheumatic-drugs-use-in-patie-peer-reviewed-fulltext-article-TCRM

Benzer Materyaller